Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Sep;86(3):825-31.
doi: 10.1172/JCI114780.

Vasoactive intestinal peptide in human nasal mucosa

J N Baraniuk  1 , J D Lundgren, M Okayama, J Mullol, M Merida, J H Shelhamer, M A Kaliner
Affiliations

Vasoactive intestinal peptide in human nasal mucosa

J N Baraniuk et al. J Clin Invest. 1990 Sep.

Abstract

Vasoactive intestinal peptide (VIP), which is present with acetylcholine in parasympathetic nerve fibers, may have important regulatory functions in mucous membranes. The potential roles for VIP in human nasal mucosa were studied using an integrated approach. The VIP content of human nasal mucosa was determined to be 2.84 +/- 0.47 pmol/g wet weight (n = 8) by RIA. VIP-immunoreactive nerve fibers were found to be most concentrated in submucosal glands adjacent to serous and mucous cells. 125I-VIP binding sites were located on submucosal glands, epithelial cells, and arterioles. In short-term explant culture, VIP stimulated lactoferrin release from serous cells but did not stimulate [3H]glucosamine-labeled respiratory glycoconjugate secretion. Methacholine was more potent than VIP, and methacholine stimulated both lactoferrin and respiratory glycoconjugate release. The addition of VIP plus methacholine to explants resulted in additive increases in lactoferrin release. Based upon the autoradiographic distribution of 125I-VIP binding sites and the effects on explants, VIP derived from parasympathetic nerve fibers may function in the regulation of serous cell secretion in human nasal mucosa. VIP may also participate in the regulation of vasomotor tone.

PubMed Disclaimer

References

    1. Ann Otol Rhinol Laryngol. 1969 Aug;78(4):865-79 - PubMed
    1. N Engl J Med. 1989 May 11;320(19):1244-8 - PubMed
    1. Acta Otolaryngol. 1980 Sep-Oct;90(3-4):304-8 - PubMed
    1. Am Rev Respir Dis. 1981 Nov;124(5):531-6 - PubMed
    1. Acta Physiol Scand. 1981;113(3):329-36 - PubMed

Publication types